Indian businessman Yusuf Hamied has an estimated net worth of $1.25 billion as of June 2016 according to Forbes. He currently chairs Cipla, a pharmaceuticals company that was founded in 1935 by Khwaja Abdul Hamied, Yusuf Hamied's father. In Africa, Hamied is hailed by the people as God, while Cipla is the temple.

Though he was raised in Mumbai, Yusuf Hamied was actually born in Vilnius, Lithuania. He is a graduate of Christ's College, Cambridge where he completed his doctorate degree in Chemistry. He is known to defy many Western pharmaceutical companies just to provide generic AIDS drugs as well as medicines for other ailments to patients in poor countries. He plays an essential role pioneering the development of several multi-drug combination pills which are used in the treatment of asthma, tuberculosis, HIV, AIDS and other serious ailments.

Because of his works, Yusuf Hamied has been featured in TIME magazine, The New York Times, The Economist, Le Monde, The Guardian, The Financial Times, Corriere della Sera, The Times (London), Wired, Der Spiegel, and other renowned publications. He was also featured on CNN, BBC, 60 Minutes and ABC News.